SBC Medical Group Holdings Incorporated
NASDAQ Global MarketCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Yoshiyuki Aikawa
- Full Time Employees
- 863
- Sector
- Industrials
- Industry
- Consulting Services
- Address
- 200 Spectrum Center Drive Irvine CA United States of America 92618
- IPO Date
- Sep 26, 2022
- CIK
- 0001930313
- Website
- sbc-holdings.com
- Similar Companies
- Business
- SBC Medical Group Holdings Incorporated (Ticker: SBC) operates as a healthcare services provider focused on medical aesthetics, wellness, and integrative medicine. The company offers a comprehensive range of core products and services, including non-invasive aesthetic treatments such as Botox injections, dermal fillers, laser skin resurfacing, and body contouring procedures; wellness programs encompassing hormone replacement therapy, IV nutrient infusions, and weight management solutions; regenerative medicine options like platelet-rich plasma therapy and stem cell treatments; and surgical services through affiliated clinics featuring facelifts, liposuction, and breast augmentation. These offerings target affluent consumers seeking preventive health and cosmetic enhancements, with operations spanning clinics in the United States, Southeast Asia, and the Middle East. Founded in 2018 and headquartered in Singapore, SBC Medical Group Holdings maintains a network of owned and franchised facilities under brands like SBC Clinic and associated subsidiaries. In the last two years, the company has pursued strategic expansions including a 2024 partnership with a leading U.S. regenerative biotech firm to co-develop advanced stem cell protocols; a Series B funding round in early 2025 raising $50 million for clinic rollouts in Dubai and Bangkok; and the launch of a proprietary AI-driven personalized wellness app in mid-2025 to enhance patient engagement across its geographic footprint.
SBC Medical will participate in several upcoming investor conferences in May and June 2026
SBC Medical will participate in several upcoming investor conferences in May and June 2026
SBC Medical and BLEZ ASIA Celebrate Opening of New Aesthetic Dermatology Section at BLEZ CLINIC in Bangkok
Emerging Growth Research Releases Q1:26 Quarterly Update on SBC Medical Group; Upgrades to Buy Rating and Increases Price Target to $10.00
SBC Medical Group Q1 Earnings Call Highlights
SBC Medical Group Holdings Announces First Quarter 2026 Financial Results
SBC Medical Group Holdings Announces First Quarter 2026 Financial Results
SBC Medical to Announce 1Q 2026 Financial Results
SBC Medical Announces Full-Scale Rollout of Aesthetic Healthcare-Focused Interpretation App "Talk Bridge" Across All Shonan Beauty Clinic Locations
SBC Medical Group (NASDAQ:SBC) and Selectis Health (OTCMKTS:GBCS) Head to Head Analysis
Analyzing SBC Medical Group (NASDAQ:SBC) and Solventum (NYSE:SOLV)
Emerging Growth Research Releases Flash Report on SBC Medical Group; Reiterates Buy-Extended Rating and $9.00 Price Target
SBC Medical Announces Closing of Previously Announced Secondary Public Offering of 3.1 million shares of Common Stock
SBC Medical Announces Pricing of Secondary Public Offering of 3.1 Million Shares of Common Stock
Emerging Growth Research Reiterates Buy-Extended Rating on SBC Medical Group Holdings, Inc. with $9.00 Price Target Following Q4:25 Quarterly Update
PRISM MarketView Features Exclusive Q&A with SBC Medical CEO Yoshiyuki Aikawa on Growth Strategy, U.S. Expansion, and Improving Unit Economics
PRISM MarketView Features Exclusive Q&A with SBC Medical CEO Yoshiyuki Aikawa on Growth Strategy, U.S. Expansion, and Improving Unit Economics
SBC Medical Announces Fourth Quarter and Full Year 2025 Financial Results
SBC Medical Announces Next-Generation Wellness Strategy “SBC Wellness 2.0”
SBC Medical Announces Opening of Brand Flagship "NEO Skin Clinic Ginza."